As at 23 March, 2021 allotted, issued and fully paid: 629,368,196 ordinary shares of £0.01 and 63,890,478 non-voting shares (which are pari passu to ordinary shares except for the lack of voting rights)

The number of ordinary shares not in public hands amount to 135,389,407 equivalent to 21.5% of the issued allotted and fully paid ordinary shares.

This is correct as of 23 March, 2021

Share Options

     

Exercise price (£)

Number of share options exercisable into ordinary shares on issue Expiry Date                                      Share options as a % of issued shares

0.30

0.27

0.33

10,000,000

13,700,000

14,655,000(2)

30 September 2024

6 July 2030

27 January 2031

1.63%

2.33%

2.38%


Share Warrants(1)

     

Exercise price (£)

Number of share warranty exercisable into non-voting shares Expiry date Share options as a % of issued shares
0.30 9,607,843 30 September 2024           1.62%

Note: (1) The share options are exercisable into ordinary shares upon exercise, whereas the warrants are convertible into non-voting shares upon exercise.

(2) On 28 January 2021, Pantheon granted up to a maximum of 14.655 million share options to all Executive Directors, certain consultants and employees under the updated Pantheon Resources plc 2009 Discretionary Share Option Plan ("Scheme"). The granted share options are vestable in two equal tranches; 50% on 27 January 2021 and 50% upon spudding of the Company's next well in Alaska, after Talitha #A. 

The Ordinary Shares of the Company have not been nor will they be registered under the United States Securities Act of 1933, as amended ("Securities Act"), or under the securities laws of any state of the United States or under the applicable securities laws of Australia, the Republic of South Africa, the Republic of Ireland, Japan or Canada.  Accordingly, subject to certain exceptions, the Ordinary Shares may not, directly or indirectly, be offered, sold, transferred, taken up or delivered, directly or indirectly, in the United States, Australia, the Republic of South Africa, the Republic of Ireland, Japan or Canada or for the benefit of any US person (as defined in Regulation S under the Securities Act).

Go To Top